Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis

scientific article published on 16 October 2014

Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1005206635
P356DOI10.1245/S10434-014-4148-X
P698PubMed publication ID25319584

P50authorIgnace Hjt de HinghQ56999746
P2093author name stringB van Ramshorst
M J Wiezer
S W Nienhuijs
M D P Luyer
H J Braam
T R van Oudheusden
P433issue4
P304page(s)1236-1242
P577publication date2014-10-16
P1433published inAnnals of Surgical OncologyQ2853069
P1476titlePeritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis
P478volume22

Reverse relations

cites work (P2860)
Q26772268Abdominal metastases from colorectal cancer: intraperitoneal therapy
Q36762307Computerized System for Staging Peritoneal Surface Malignancies
Q64983651Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques.
Q58806095Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis
Q26774607Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases
Q98281046Spectral photon-counting CT imaging of colorectal peritoneal metastases: initial experience in rats
Q89689902Surgeons' Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Q28067123Therapeutic options for peritoneal metastasis arising from colorectal cancer
Q60919176Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases